Glenmark Pharmaceuticals Ltd

Glenmark Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Glenmark Pharmaceuticals Ltd

₹ 1,249 -1.46%
02 Jul - close price
glenmarkpharma.com BSE: 532296 NSE: GLENMARK
About

Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries.[1]

Key Points

Leadership[1]

<h1>14th largest and fastest growing in the Indian market</h1> <h1>15th largest generic company by prescriptions filled in the USA</h1> <h1>5th largest Indian generic co. in Europe.</h1>
Website BSE NSE
  • Market Cap ₹ 35,244 Cr.
  • Current Price ₹ 1,249
  • High / Low ₹ 1,272 / 649
  • Stock P/E
  • Book Value ₹ 278
  • Dividend Yield 0.20 %
  • ROCE 12.4 %
  • ROE -32.3 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Debtor days have improved from 88.2 to 57.4 days.
  • Company's working capital requirements have reduced from 80.8 days to 31.8 days

Cons

  • Stock is trading at 4.49 times its book value
  • The company has delivered a poor sales growth of 3.67% over past five years.
  • Company has a low return on equity of -4.59% over last 3 years.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
2,860 2,965 3,147 3,173 3,019 2,777 3,018 3,100 3,001 3,036 3,207 2,507 3,063
2,336 2,391 2,557 2,480 2,556 2,346 2,539 2,626 2,603 2,599 2,745 2,715 2,559
Operating Profit 523 574 590 693 463 432 479 474 398 437 462 -209 504
OPM % 18% 19% 19% 22% 15% 16% 16% 15% 13% 14% 14% -8% 16%
8 59 -13 -164 25 183 86 209 -696 -32 -205 87 351
Interest 83 76 69 67 87 60 83 97 109 112 121 134 149
Depreciation 111 113 123 119 132 147 146 152 135 142 141 147 151
Profit before tax 338 444 385 343 270 408 337 435 -542 151 -6 -403 555
Tax % 31% 31% 29% 30% 36% 48% 17% 33% 26% -14% -997% 18% 319%
234 307 275 240 173 211 279 291 -403 173 -62 -331 -1,214
EPS in Rs 8.29 10.86 9.13 7.86 5.51 6.82 9.23 9.66 -15.18 5.31 -2.90 -12.45 -43.17
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
5,012 6,005 6,563 7,562 9,079 9,074 9,865 10,641 10,944 12,305 12,990 11,813
3,997 4,914 5,348 6,125 7,043 7,457 8,280 8,942 8,860 9,978 10,712 10,618
Operating Profit 1,015 1,091 1,214 1,437 2,037 1,617 1,586 1,699 2,084 2,327 2,278 1,195
OPM % 20% 18% 18% 19% 22% 18% 16% 16% 19% 19% 18% 10%
11 11 -180 20 -44 89 375 191 95 -101 -449 336
Interest 160 189 190 179 237 286 335 377 353 298 350 516
Depreciation 127 217 300 234 264 302 326 417 444 487 611 582
Profit before tax 739 697 544 1,044 1,491 1,119 1,301 1,096 1,382 1,441 868 434
Tax % 15% 22% 61% 29% 26% 28% 29% 29% 30% 31% 57% 430%
628 546 209 743 1,109 804 925 776 970 994 377 -1,434
EPS in Rs 22.89 19.99 7.72 26.33 39.29 28.49 32.78 27.50 34.38 33.37 10.53 -53.22
Dividend Payout % 0% 0% 26% 8% 5% 7% 6% 9% 7% 7% 24% -5%
Compounded Sales Growth
10 Years: 7%
5 Years: 4%
3 Years: 3%
TTM: -9%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -654%
Stock Price CAGR
10 Years: 8%
5 Years: 24%
3 Years: 24%
1 Year: 92%
Return on Equity
10 Years: 7%
5 Years: 1%
3 Years: -5%
Last Year: -32%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 27 27 27 28 28 28 28 28 28 28 28 28
Reserves 2,736 2,956 1,756 3,601 4,464 5,135 5,577 6,042 7,036 9,058 9,446 7,820
2,765 3,267 3,800 3,988 4,724 4,639 4,449 4,869 4,986 3,962 4,627 1,231
1,466 2,176 2,726 2,575 2,548 2,793 3,235 3,729 3,524 4,003 5,228 5,280
Total Liabilities 6,994 8,427 8,309 10,193 11,764 12,595 13,289 14,668 15,575 17,052 19,329 14,359
2,822 3,091 2,015 2,594 2,755 3,030 3,670 5,029 5,129 5,887 6,202 4,453
CWIP 6 5 477 543 708 1,122 1,399 1,222 1,382 1,010 1,251 419
Investments 0 0 17 17 16 15 30 25 25 50 45 790
4,166 5,331 5,799 7,039 8,285 8,429 8,190 8,393 9,040 10,105 11,830 8,697
Total Assets 6,994 8,427 8,309 10,193 11,764 12,595 13,289 14,668 15,575 17,052 19,329 14,359

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
648 854 482 345 657 1,648 1,324 1,392 1,131 1,109 625 -265
-558 -566 -712 -950 -1,001 -1,003 -883 -774 -662 -316 -515 4,561
195 -98 199 699 543 -468 -739 -445 -442 -520 -77 -3,906
Net Cash Flow 285 190 -31 93 199 177 -297 174 28 272 32 389

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 119 131 140 120 97 94 81 83 86 92 115 57
Inventory Days 194 191 247 249 299 244 244 211 230 208 240 208
Days Payable 239 279 379 308 243 225 241 210 226 190 192 210
Cash Conversion Cycle 75 43 8 61 152 113 85 84 90 110 162 56
Working Capital Days 94 83 66 89 133 111 76 69 96 100 111 32
ROCE % 18% 15% 16% 19% 21% 15% 15% 14% 15% 16% 14%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
46.63% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65% 46.65%
26.82% 25.93% 24.18% 24.12% 24.23% 23.14% 23.19% 22.47% 25.51% 24.79% 23.71% 21.38%
9.73% 9.03% 10.86% 10.96% 10.50% 10.90% 10.69% 10.40% 9.10% 10.31% 10.92% 13.36%
0.00% 0.00% 0.00% 0.00% 0.00% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
16.82% 18.40% 18.31% 18.27% 18.63% 19.27% 19.45% 20.46% 18.70% 18.21% 18.70% 18.58%
No. of Shareholders 2,75,8013,29,8703,17,3833,10,5163,12,4733,13,5403,00,1062,85,4612,36,9082,32,6852,09,9311,99,451

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls